Brevican (BCAN) which is known to bind to tenascin-R (TNR) with high affinity [33], is highly expressed in gliomas, initiating cells’ extracellular niche in human GBM tumors and is expressed by glioma initiating cells in vitro [34]. The gene discussed is BCAN; the disease is central nervous system cancer.